Safeguard Scientifics, Inc.

  • Market Cap: N/A
  • Industry: Capital Markets
  • ISIN: US7864493066
USD
0.74
-0.01 (-1.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Safeguard Scientifics, Inc. stock-summary
stock-summary
Safeguard Scientifics, Inc.
Capital Markets
Safeguard Scientifics, Inc. is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies. The Company offers operational and management support to each of its partner companies. In addition to management and operational support, the Company offers ongoing planning and development assessment. It provides mentoring, advice and guidance to develop partner company management. The Company serves on the boards of directors of its partner companies, working with them to develop and implement strategic and operating plans. It measures and monitors achievement of these plans through regular review of operational and financial performance measurements.
Company Coordinates stock-summary
Company Details
150 NORTH RADNOR-CHESTER ROAD, SUITE F-200 RADNOR PA : 19087
stock-summary
Tel: 1 610 29306001 610 9754913
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 7 Schemes (5.59%)

Foreign Institutions

Held by 6 Foreign Institutions (0.73%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Robert Rosenthal
Chairman of the Board
Mr. Russell Glass
Independent Director
Mr. Joseph Manko
Independent Director
Ms. Maureen Morrison
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2025)
Net Profit:
-1 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 14 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

-100.85%

stock-summary
Price to Book

1.51